In diabetic nephropathy, lncRNA SPAG5-AS1 activates the AKT/mTOR pathway through upregulation of SPAG5 to foster apoptosis and abate autophagy in high glucose- (HG-) treated human podocytes (HPCs) [27]. This evidence concerns the gene SPAG5 and diabetic kidney disease.